Adverse events occurring in less than 20% of patients
| Adverse event . | Treated with ABX-CBL, no. (%) . | Treated with ATG, no. (%) . |
|---|---|---|
| Infections and infestations* | 45 (97.8) | 46 (100) |
| Blood culture positive | 26 (56.5) | 21 (45.7) |
| Hypertension | 14 (30.4) | 13 (28.3) |
| Graft-versus-host disease | 16 (34.8) | 10 (21.7) |
| Hyperglycemia | 11 (23.9) | 12 (26.1) |
| Neutropenia | 10 (21.7) | 13 (28.3) |
| Pyrexia | 9 (19.6) | 14 (30.4) |
| Abdominal pain | 7 (15.2) | 15 (32.6) |
| Edema | 14 (30.4) | 8 (17.4) |
| Depression | 11 (23.9) | 10 (21.7) |
| Hypotension | 10 (21.7) | 11 (23.9) |
| Back pain | 11 (23.9) | 8 (17.4) |
| Cough | 6 (13.0) | 13 (28.3) |
| Dyspnea | 8 (17.4) | 11 (23.9) |
| Rigors | 7 (15.2) | 12 (26.1) |
| Hypocalcemia | 10 (21.7) | 8 (17.4) |
| Myalgia | 14 (30.4) | 3 (6.5) |
| Edema lower limb | 4 (8.7) | 13 (28.3) |
| Thrombocytopenia | 10 (21.7) | 7 (15.2) |
| Headache | 5 (10.9) | 11 (23.9) |
| Renal impairment | 6 (13.0) | 10 (21.7) |
| Arthralgia | 5 (10.9) | 10 (21.7) |
| Gastrointestinal hemorrhage | 4 (8.7) | 10 (21.7) |
| Adverse event . | Treated with ABX-CBL, no. (%) . | Treated with ATG, no. (%) . |
|---|---|---|
| Infections and infestations* | 45 (97.8) | 46 (100) |
| Blood culture positive | 26 (56.5) | 21 (45.7) |
| Hypertension | 14 (30.4) | 13 (28.3) |
| Graft-versus-host disease | 16 (34.8) | 10 (21.7) |
| Hyperglycemia | 11 (23.9) | 12 (26.1) |
| Neutropenia | 10 (21.7) | 13 (28.3) |
| Pyrexia | 9 (19.6) | 14 (30.4) |
| Abdominal pain | 7 (15.2) | 15 (32.6) |
| Edema | 14 (30.4) | 8 (17.4) |
| Depression | 11 (23.9) | 10 (21.7) |
| Hypotension | 10 (21.7) | 11 (23.9) |
| Back pain | 11 (23.9) | 8 (17.4) |
| Cough | 6 (13.0) | 13 (28.3) |
| Dyspnea | 8 (17.4) | 11 (23.9) |
| Rigors | 7 (15.2) | 12 (26.1) |
| Hypocalcemia | 10 (21.7) | 8 (17.4) |
| Myalgia | 14 (30.4) | 3 (6.5) |
| Edema lower limb | 4 (8.7) | 13 (28.3) |
| Thrombocytopenia | 10 (21.7) | 7 (15.2) |
| Headache | 5 (10.9) | 11 (23.9) |
| Renal impairment | 6 (13.0) | 10 (21.7) |
| Arthralgia | 5 (10.9) | 10 (21.7) |
| Gastrointestinal hemorrhage | 4 (8.7) | 10 (21.7) |
For both groups, n = 46.
*This includes all preferred terms in the System Organ Class “Infections and Infestations.”